Compare CDNL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNL | CTKB |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.6M | 777.3M |
| IPO Year | 2025 | 2021 |
| Metric | CDNL | CTKB |
|---|---|---|
| Price | $15.29 | $5.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $47.25 | $6.17 |
| AVG Volume (30 Days) | ★ 1.2M | 1.2M |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $456,045,369.00 | $193,015,000.00 |
| Revenue This Year | $95.00 | $3.82 |
| Revenue Next Year | $24.54 | $6.49 |
| P/E Ratio | $27.04 | ★ N/A |
| Revenue Growth | ★ 44.69 | 17.67 |
| 52 Week Low | $12.51 | $3.31 |
| 52 Week High | $96.40 | $6.34 |
| Indicator | CDNL | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 55.31 |
| Support Level | $13.05 | $4.10 |
| Resistance Level | $27.68 | $6.27 |
| Average True Range (ATR) | 1.21 | 0.35 |
| MACD | 0.68 | -0.02 |
| Stochastic Oscillator | 71.60 | 59.82 |
Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. The company provides wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. It derives all revenue in the United States of America from construction projects based in North Carolina and South Carolina.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.